News

BrightNight Welcomes Scott Bolton as New VP of External Affairs

BrightNight Welcomes Scott Bolton as New VP of External Affairs

BrightNight Appoints New Leadership to Propel Growth

BrightNight, an innovative power and digital infrastructure company, is thrilled to announce the addition of Scott Bolton as its Senior Vice President of External Affairs. As the company continues to expand its portfolio and influence in the energy sector, Scott’s expertise will be invaluable.

Strategic Leadership for Market Expansion

In his role, Scott will spearhead BrightNight's public policy initiatives, regulatory efforts, and strategic communications. His leadership will play a crucial role as the company seeks to enhance its market presence and develop assets effectively.

A Wealth of Experience in the Energy Sector

Scott Bolton comes to BrightNight with over 25 years of experience in the energy industry. Before joining BrightNight, he held the position of Executive Vice President at Hydrostor, a premier global developer renowned for its long-duration energy storage solutions. His extensive background includes nearly two decades at PacifiCorp, one of the largest electric utilities in the Western United States. During his tenure, he played a pivotal role in shaping transformative energy legislation, establishing widely recognized customer programs, and driving the advancement of innovative power markets.

Accelerating the Digital Transformation

As BrightNight significantly scales its ambitious 35-gigawatt energy generation and storage portfolio across the country, Scott's extensive industry knowledge and network will enable accelerated deployment of state-of-the-art energy solutions. This is particularly crucial as the demand from utilities and digital infrastructure operators continues to surge.

BrightNight’s Vision and Commitment

Scott’s appointment aligns seamlessly with BrightNight's commitment to powering America's industrial resurgence and digital innovation through clean, reliable, and competitively priced energy. His role is not merely about leadership; it’s about steering the company towards a future where clean energy is pivotal for industrial and technological advancement.

About BrightNight

BrightNight is a cutting-edge power and digital infrastructure firm specifically designed to cater to the dynamic requirements of utilities, data centers, and commercial and industrial customers. The company focuses on the design, development, and operation of expansive energy and infrastructure sites that marry utility-scale renewable energy with state-of-the-art gas generation, battery storage, and optimized power solutions tailored for digital infrastructure.

Industry-Leading Power Projects

With a robust portfolio of 35 gigawatts of top-tier power projects, BrightNight is positioned in the most vibrant energy markets and data center hotspots across the United States. This strategic positioning not only enhances the company’s growth potential but also solidifies its role as a leader in the clean energy transition.

Harnessing AI for Peak Performance

One of the cornerstones of BrightNight’s innovative approach is its proprietary AI platform, PowerAlpha®. This advanced technology empowers the company to deliver exceptional economic performance and uptime, ensuring that customers receive unparalleled reliability in their energy solutions.

Frequently Asked Questions

Who is Scott Bolton?

Scott Bolton is the newly appointed Senior Vice President of External Affairs at BrightNight, bringing extensive experience from the energy sector.

What are the responsibilities of Scott Bolton at BrightNight?

Scott will lead public policy, regulatory affairs, and strategic communications to support BrightNight's market expansion.

What is BrightNight's primary focus?

BrightNight is dedicated to delivering clean and dispatchable energy solutions while enhancing digital infrastructure through innovative technologies.

How does BrightNight leverage technology in its operations?

BrightNight utilizes its proprietary AI platform, PowerAlpha®, to optimize economic performance and uptime across its energy solutions.

What kinds of projects does BrightNight develop?

BrightNight designs and operates large-scale energy sites integrating renewables, gas generation, and energy storage systems.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise of the Aluminum Alloy Wheel Market

Updated Category News Views 91

Overview of the Aluminum Alloy Wheel Market The Aluminum Alloy Wheel market has experienced notable growth and shows a bright future ahead. With ongoing innovations from manufacturers and shifting consumer preferences, the market is projected to reach approximately USD 33.2 billion by 2033. This growth translates to an estimated compound annual growth rate (CAGR) of 7.2%...

Continue Reading
Prominent Speakers Set to Illuminate Fortune Global Forum

Updated Category News Views 191

Global Icons to Speak at Fortune Global Forum 2024 Excitement is building around the upcoming Fortune Global Forum, where some of the most influential leaders in business and policy will converge. This event, set for November 11-12, promises rich dialogues on pressing global issues. Among the key figures attending are Tom Brady, the renowned seven-time world champion, and...

Continue Reading
IGT Unveils Diverse Wheel of Fortune Products at G2E 2024

Updated Category News Views 187

IGT Launches Exciting New Offerings for Wheel of Fortune International Game Technology PLC, better known as IGT, is famous for creating vibrant and engaging gaming experiences. At the upcoming Global Gaming Expo (G2E), IGT will proudly showcase a range of new products dedicated to the beloved Wheel of Fortune brand. Attendees can look forward to an exciting lineup that...

Continue Reading
Market Dynamics and Short Selling Insights About Disney

Updated Category News Views 132

Understanding Short Selling for Walt Disney Walt Disney's short percent of float has experienced a notable increase, now standing at 8.04% from the latest report. Presently, there are 21.70 million shares sold short, which accounts for 1.21% of all available regular shares. With the current trading volume, it is estimated that it would take around 3.12 days on average for...

Continue Reading
Heritage Commerce Corp Announces Quarterly Dividend of $0.13

Updated Category News Views 155

Heritage Commerce Corp Declares Dividend to Shareholders Heritage Commerce Corp (NASDAQ: HTBK), a respected bank holding company in the financial sector, recently shared exciting news with its stakeholders. The Board of Directors has approved a cash dividend of $0.13 per share for all common stock holders. This positive announcement reflects the company's commitment to...

Continue Reading